HLI - Houlihan Lokey, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$163.60
DETAILS
HIGH:
$187.00
LOW:
$145.00
MEDIAN:
$161.00
CONSENSUS:
$163.60
UPSIDE:
19.97%
AlphaVal
Deterministic, archetype-aware fair value
Banks, Insurers & Asset Managers
85% confidence
Primary model: P/Tangible Book × ROE Quality
Adjust Assumptions
57.3%
9.6%
Key Value Driver
ROTCE (57.3%) vs. cost of equity (9.6%)
Implied Market Multiple
12.84x
Plain-Language Summary
With ROTCE of 57.3% vs. 9.6% cost of equity, fair P/TBV is 3.74x on $10.62 tangible book, implying $104.76 per share. DDM cross-check: $82.04.
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.
Average Target (15 analysts)
$163.60
Analyst Range
$145.00 – $187.00
Divergence from AlphaVal
36%
Warnings
Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $163.60 (from 15 analysts). Our estimate is 36% below the consensus -- consider that gap carefully.
Key Risks
- Book value quality matters as much as level — check loan loss reserves
- Interest rate sensitivity creates non-linear earnings surprises
- Insurance reserving is actuarial, not financial — errors emerge slowly